{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T20:29:38Z","timestamp":1778617778717,"version":"3.51.4"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T00:00:00Z","timestamp":1543449600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Grants-in-Aid for Scientific Research","award":["25293260, 15K15452"],"award-info":[{"award-number":["25293260, 15K15452"]}]},{"name":"Grants-in-Aid for Scientific Research","award":["15K09949, 16KK0200"],"award-info":[{"award-number":["15K09949, 16KK0200"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1007\/s11095-018-2548-5","type":"journal-article","created":{"date-parts":[[2018,11,29]],"date-time":"2018-11-29T16:52:51Z","timestamp":1543510371000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Different Efflux Transporter Affinity and Metabolism of 99mTc-2-Methoxyisobutylisonitrile and 99mTc-Tetrofosmin for Multidrug Resistance Monitoring in Cancer"],"prefix":"10.1007","volume":"36","author":[{"given":"Masato","family":"Kobayashi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Tsujiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Okui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kodai","family":"Nishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeo","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuichi","family":"Nishii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuki","family":"Fukuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikumi","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,11,29]]},"reference":[{"key":"2548_CR1","doi-asserted-by":"publisher","first-page":"685","DOI":"10.4161\/cbt.2.6.557","volume":"2","author":"A Lockhart","year":"2003","unstructured":"Lockhart A, Tirona L, Kim R. Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy. Mol Cancer Ther. 2003;2:685\u201398.","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2548_CR2","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1097\/00045415-200105000-00009","volume":"9","author":"P Kailasnath","year":"2001","unstructured":"Kailasnath P, Sinusas AJ. Technetium-99m-labeled myocardial perfusion agents: are they better than thallium-201? Cardiol Rev. 2001;9(3):160\u201372.","journal-title":"Cardiol Rev"},{"issue":"2","key":"2548_CR3","first-page":"133","volume":"49","author":"O Schillaci","year":"2005","unstructured":"Schillaci O, Spanu A, Madeddu G. [99mTc]sestamibi and [99mTc]tetrofosmin in oncology: SPECT and fusion imaging in lung cancer, malignant lymphomas and brain tumors. Q J Nucl Med Mol Imaging. 2005;49(2):133\u201344.","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"2548_CR4","first-page":"228","volume":"39","author":"L Kostakoglu","year":"1998","unstructured":"Kostakoglu L, Kiratli P, Ruacan S, Hayran M, Emri S, Erg\u00fcn EL, et al. Association of tumor washout rates and accumulation of technetium-99m-MIBI with expression of P-glycoprotein in lung cancer. J Nucl Med. 1998;39:228\u201334.","journal-title":"J Nucl Med"},{"key":"2548_CR5","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12149-015-0980-8","volume":"29","author":"S Kurata","year":"2015","unstructured":"Kurata S, Ushijima K, Kawahara A, Kaida H, Kawano K, Hirose Y, et al. Assessment of 99mTc-MIBI SPECT(\/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study. Ann Nucl Med. 2015;29:643\u20139.","journal-title":"Ann Nucl Med"},{"key":"2548_CR6","first-page":"977","volume":"53","author":"D Piwnica-Worms","year":"1993","unstructured":"Piwnica-Worms D, Chiu ML, Budding M, Kronauge JF, Kramer RA, Croop JM. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 1993;53:977\u201384.","journal-title":"Cancer Res"},{"key":"2548_CR7","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00259-003-1268-0","volume":"30","author":"S Kinuya","year":"2003","unstructured":"Kinuya S, Li XF, Yokoyama K, Mori H, Shiba K, Watanabe N, et al. Reduction of 99mTc-sestamibi and 99mTc-tetrofosmin uptake in MRP-expressing breast cancer cells under hypoxic conditions is independent of MRP function. Eur J Nucl Med Mol Imaging. 2003;30:1529\u201331.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2548_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1089\/cbr.2008.0539","volume":"24","author":"CM Gomes","year":"2009","unstructured":"Gomes CM, Abrunhosa AJ, Pauwels EK, Botelho MF. P-glycoprotein versus MRP1 on transport kinetics of cationic lipophilic substrates: a comparative study using [99mTc]sestamibi and [99mTc]tetrofosmin. Cancer Biother Radiopharm. 2009;24:215\u201327.","journal-title":"Cancer Biother Radiopharm"},{"key":"2548_CR9","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/sj.bjc.6606071","volume":"104","author":"M Yamasaki","year":"2011","unstructured":"Yamasaki M, Makino T, Masuzawa T, Kurokawa Y, Miyata H, Takiguchi S, et al. Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma. Br J Cancer. 2011;104:707\u201313.","journal-title":"Br J Cancer"},{"key":"2548_CR10","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1158\/0008-5472.CAN-08-0234","volume":"68","author":"C O'Brien","year":"2008","unstructured":"O'Brien C, Cavet G, Pandita A, Hu X, Haydu L, Mohan S, et al. Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res. 2008;68:5380\u20139.","journal-title":"Cancer Res"},{"key":"2548_CR11","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00428-013-1390-8","volume":"462","author":"M Montani","year":"2013","unstructured":"Montani M, Hermanns T, M\u00fcntener M, Wild P, Sulser T, Kristiansen G. Multidrug resistance protein 4 (MRP4) expression in prostate cancer is associated with androgen signaling and decreases with tumor progression. Virchows Arch. 2013;462:437\u201343.","journal-title":"Virchows Arch"},{"key":"2548_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.5732\/cjc.011.10320","volume":"31","author":"T Nakanishi","year":"2012","unstructured":"Nakanishi T, Ross DD. Breast cancer resistance protein (BCRP\/ABCG2): its role in multidrug resistance and regulation of its gene expression. Chin J Cancer. 2012;31:73\u201399.","journal-title":"Chin J Cancer"},{"key":"2548_CR13","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.nucmedbio.2014.01.004","volume":"41","author":"M Kobayashi","year":"2014","unstructured":"Kobayashi M, Nakanishi T, Nishi K, Higaki Y, Okudaira H, Ono M, et al. Transport mechanism of hepatic uptake and bile excretion in clinical hepatobiliary scintigraphy with 99mTc-N-pyridoxyl-5-methyltryptophan. Nucl Med Biol. 2014;41:338\u201342.","journal-title":"Nucl Med Biol"},{"key":"2548_CR14","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/j.nucmedbio.2012.06.006","volume":"39","author":"M Kobayashi","year":"2012","unstructured":"Kobayashi M, Hashimoto F, Ohe K, Nadamura T, Nishi K, Shikano N, et al. Transport mechanism of 11C-labeled L- and D-methionine in human-derived tumor cells. Nucl Med Biol. 2012;39:1213\u20138.","journal-title":"Nucl Med Biol"},{"key":"2548_CR15","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1124\/dmd.113.052514","volume":"41","author":"LA Mohamed","year":"2013","unstructured":"Mohamed LA, Kaddoumi A. In vitro investigation of amyloid-\u03b2 hepatobiliary disposition in sandwich-cultured primary rat hepatocytes. Drug Metab Dispos. 2013;41:1787\u201396.","journal-title":"Drug Metab Dispos"},{"key":"2548_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1021\/mp050101+","volume":"3","author":"S Sakamoto","year":"2006","unstructured":"Sakamoto S, Suzuki H, Kusuhara H, Sugiyama Y. Efflux mechanism of taurocholate across the rat intestinal basolateral membrane. Mol Pharm. 2006;3:275\u201381.","journal-title":"Mol Pharm"},{"key":"2548_CR17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.pharmthera.2011.11.009","volume":"133","author":"JR Reed","year":"2012","unstructured":"Reed JR, Backes WL. Formation of P450. P450 complexes and their effect on P450 function. Pharmacol Ther. 2012;133:299\u2013310.","journal-title":"Pharmacol Ther"},{"key":"2548_CR18","unstructured":"Japan Radiopharmaceuticals Association: The Minimum Requirements for Radiopharmaceuticals. \n                    http:\/\/www.houyakkyou.org\/img\/housha_img\/kaisetsu_160630.pdf\n                    \n                  . Accessed 5 Aug 2018."},{"key":"2548_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1097\/00006231-200110000-00014","volume":"22","author":"T M\u00e9tay\u00e9","year":"2001","unstructured":"M\u00e9tay\u00e9 T, Desmarquet M, Rosenberg T, Guilhot J, Bouin-Pineau MH. Rapid quality control for testing the radiochemical purity of 99Tc(m)-tetrofosmin. Nucl Med Commun. 2001;22:1139\u201344.","journal-title":"Nucl Med Commun"},{"key":"2548_CR20","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1146\/annurev.pharmtox.44.101802.121444","volume":"45","author":"Y Shitara","year":"2005","unstructured":"Shitara Y, Sato H, Sugiyama Y. Evaluation of drug-drug interaction in the hepatobiliary and renal transport of drugs. Annu Rev Pharmacol Toxicol. 2005;45:689\u2013723.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2548_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/2191-219X-2-21","volume":"2","author":"A Vrachimis","year":"2012","unstructured":"Vrachimis A, Hermann S, M\u00e1th\u00e9 D, Schober O, Sch\u00e4fers M. Systematic evaluation of 99mTc-tetrofosmin versus 99mTc-sestamibi to study murine myocardial perfusion in small animal SPECT\/CT. EJNMMI Res. 2012;2:21.","journal-title":"EJNMMI Res"},{"issue":"3","key":"2548_CR22","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S0969-8051(00)00085-8","volume":"27","author":"N Perek","year":"2000","unstructured":"Perek N, Prevot N, Koumanov F, Frere D, Sabido O, Beauchesne P, et al. Involvement of the glutathione S-conjugate compounds and the MRP protein in Tc-99m-tetrofosmin and Tc-99m-sestamibi uptake in glioma cell lines. Nucl Med Biol. 2000;27(3):299\u2013307.","journal-title":"Nucl Med Biol"},{"issue":"3","key":"2548_CR23","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1089\/cbr.2005.20.249","volume":"20","author":"N Jeune Le","year":"2005","unstructured":"Le Jeune N, Perek N, Denoyer D, Dubois F. Study of monoglutathionyl conjugates TC-99M-sestamibi and TC-99M-tetrofosmin transport mediated by the multidrug resistance-associated protein isoform 1 in glioma cells. Cancer Biother Radiopharm. 2005;20(3):249\u201359.","journal-title":"Cancer Biother Radiopharm"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-018-2548-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-018-2548-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,29]],"date-time":"2019-11-29T00:14:54Z","timestamp":1574986494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-018-2548-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,29]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["2548"],"URL":"https:\/\/doi.org\/10.1007\/s11095-018-2548-5","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,29]]},"assertion":[{"value":"2 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"18"}}